123 related articles for article (PubMed ID: 28937943)
1. Multiomics Analysis of Tumor Microenvironment Reveals Gata2 and miRNA-124-3p as Potential Novel Biomarkers in Ovarian Cancer.
Gov E; Kori M; Arga KY
OMICS; 2017 Oct; 21(10):603-615. PubMed ID: 28937943
[TBL] [Abstract][Full Text] [Related]
2. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
[TBL] [Abstract][Full Text] [Related]
3. Identification of Prognostic Biomarker Signatures and Candidate Drugs in Colorectal Cancer: Insights from Systems Biology Analysis.
Rahman MR; Islam T; Gov E; Turanli B; Gulfidan G; Shahjaman M; Banu NA; Mollah MNH; Arga KY; Moni MA
Medicina (Kaunas); 2019 Jan; 55(1):. PubMed ID: 30658502
[TBL] [Abstract][Full Text] [Related]
4. A systems biology approach to identify microRNAs contributing to cisplatin resistance in human ovarian cancer cells.
Liu W; Wang S; Zhou S; Yang F; Jiang W; Zhang Q; Wang L
Mol Biosyst; 2017 Oct; 13(11):2268-2276. PubMed ID: 28861582
[TBL] [Abstract][Full Text] [Related]
5. Ovarian Cancer: Differentially Expressed microRNAs in Tumor Tissue and Cell-Free Ascitic Fluid as Potential Novel Biomarkers.
Záveský L; Jandáková E; Weinberger V; Minář L; Hanzíková V; Dušková D; Drábková LZ; Hořínek A
Cancer Invest; 2019; 37(9):440-452. PubMed ID: 31530033
[TBL] [Abstract][Full Text] [Related]
6. Ovarian Cancer Differential Interactome and Network Entropy Analysis Reveal New Candidate Biomarkers.
Ayyildiz D; Gov E; Sinha R; Arga KY
OMICS; 2017 May; 21(5):285-294. PubMed ID: 28375712
[TBL] [Abstract][Full Text] [Related]
7. Targeting the tumor stroma: integrative analysis reveal GATA2 and TORYAIP1 as novel prognostic targets in breast and ovarian cancer.
Erceylan ÖF; Savaş A; Göv E
Turk J Biol; 2021; 45(2):127-137. PubMed ID: 33907495
[TBL] [Abstract][Full Text] [Related]
8. Molecular signatures of ovarian diseases: Insights from network medicine perspective.
Kori M; Gov E; Arga KY
Syst Biol Reprod Med; 2016 Aug; 62(4):266-82. PubMed ID: 27341345
[TBL] [Abstract][Full Text] [Related]
9. Identification of molecular signatures and pathways to identify novel therapeutic targets in Alzheimer's disease: Insights from a systems biomedicine perspective.
Rahman MR; Islam T; Zaman T; Shahjaman M; Karim MR; Huq F; Quinn JMW; Holsinger RMD; Gov E; Moni MA
Genomics; 2020 Mar; 112(2):1290-1299. PubMed ID: 31377428
[TBL] [Abstract][Full Text] [Related]
10. Biomarker identification in clear cell renal cell carcinoma based on miRNA-seq and digital gene expression-seq data.
Guan L; Tan J; Li H; Jin X
Gene; 2018 Mar; 647():205-212. PubMed ID: 29253611
[TBL] [Abstract][Full Text] [Related]
11. Targeting miR-21-3p inhibits proliferation and invasion of ovarian cancer cells.
Báez-Vega PM; Echevarría Vargas IM; Valiyeva F; Encarnación-Rosado J; Roman A; Flores J; Marcos-Martínez MJ; Vivas-Mejía PE
Oncotarget; 2016 Jun; 7(24):36321-36337. PubMed ID: 27166999
[TBL] [Abstract][Full Text] [Related]
12. Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing.
Chang YY; Kuo WH; Hung JH; Lee CY; Lee YH; Chang YC; Lin WC; Shen CY; Huang CS; Hsieh FJ; Lai LC; Tsai MH; Chang KJ; Chuang EY
Mol Cancer; 2015 Feb; 14():36. PubMed ID: 25888956
[TBL] [Abstract][Full Text] [Related]
13. Potential biomarkers and therapeutic targets in cervical cancer: Insights from the meta-analysis of transcriptomics data within network biomedicine perspective.
Kori M; Yalcin Arga K
PLoS One; 2018; 13(7):e0200717. PubMed ID: 30020984
[TBL] [Abstract][Full Text] [Related]
14. The clinical impact of intra- and extracellular miRNAs in ovarian cancer.
Yoshida K; Yokoi A; Kato T; Ochiya T; Yamamoto Y
Cancer Sci; 2020 Oct; 111(10):3435-3444. PubMed ID: 32750177
[TBL] [Abstract][Full Text] [Related]
15. A transcriptome-based global map of signaling pathways in the ovarian cancer microenvironment associated with clinical outcome.
Reinartz S; Finkernagel F; Adhikary T; Rohnalter V; Schumann T; Schober Y; Nockher WA; Nist A; Stiewe T; Jansen JM; Wagner U; Müller-Brüsselbach S; Müller R
Genome Biol; 2016 May; 17(1):108. PubMed ID: 27215396
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
[TBL] [Abstract][Full Text] [Related]
17. [Detection and correlation analysis of miRNAs and myeloid-derived suppressor cells in ovarian cancer-bearing mice].
Liu Y; Lin X; Bao T; Ni P; Xie C; Shen H; Xu W; Xu H; Su Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Apr; 31(4):467-9, 473. PubMed ID: 25854564
[TBL] [Abstract][Full Text] [Related]
18. Acute Myeloid Leukemia: New Multiomics Molecular Signatures and Implications for Systems Medicine Diagnostics and Therapeutics Innovation.
Kelesoglu N; Kori M; Turanli B; Arga KY; Yilmaz BK; Duru OA
OMICS; 2022 Jul; 26(7):392-403. PubMed ID: 35763314
[TBL] [Abstract][Full Text] [Related]
19. A novel framework for inferring condition-specific TF and miRNA co-regulation of protein-protein interactions.
Zhang J; Le TD; Liu L; He J; Li J
Gene; 2016 Feb; 577(1):55-64. PubMed ID: 26611531
[TBL] [Abstract][Full Text] [Related]
20. The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma.
Kinose Y; Sawada K; Nakamura K; Sawada I; Toda A; Nakatsuka E; Hashimoto K; Mabuchi S; Takahashi K; Kurachi H; Lengyel E; Kimura T
Oncotarget; 2015 May; 6(13):11342-56. PubMed ID: 25839163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]